Clindamycin phosphate (1%) and Benzoyl peroxide (5%) gel (Duac®Gel): perrigo announced settlement with innovator
Generic player Perrigo has settled pending litigation with innovator Stiefel Laboratories (a division of Glaxo SmithKline) on Clindamycin phosphate (1%) and Benzoyl peroxide (5%) gel (Duac®Gel). Eralier, perrigo purchased the ANDA (as reported by Perrigo Here ) for this product from first para IV filer KV pharma.
Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
Pharma Giant Eli Lilly and Company announced (in a press release Here ) the sale of its Tippecanoe Laboratories manufacturing facility to Evonik Industries AG, one of the world's largest chemical companies
Update on Oct 22, 2009
Dr. Suresh Pillai of Patent docs has reviewed the following interesting cases:
1) Escitalopram (Lexapro)
2) Memantine (Namenda)
3) Moxifloxacin (Vigamox)
For details, please check following link:
No comments:
Post a Comment